Reality folks No sales contracts and no mention of any
company will only update on sales every quarter meaning next update March 31
Roche and Abbott have already squeezed out all other antigen tests in Europe of which there are many all with Ce mark
price Roche and Abbott are selling for in Europe is $6 USD
Why would European customers be interested in Sona when there are so many other tests in the market including Roche and Abbott who have fda and hc approvals and have already signed big contracts ?
HC said they wanted more data before they would consider test
FDA said they weren't interested in approving their test as EUA
havent started clinical trials yet for resubmission to HC or fda for nasalpharyngal test
Haven't completed prototype yet for saliva test
may least one lawsuit has been filed against the company
tell me again why anyone other than a short would be interested in this stock right now with a $200m+ market cap ? Just asking